Open AccessRelationship between toxicities and clinical benefits of newly approved tyrosine kinase inhibitors in thyroid cancer: A meta-analysis of literature
Author(s) -
Xiaobing Ye,
Yiping Zhu,
Juan Cai
Publication year - 2015
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.168182
Subject(s) - lenvatinib , sorafenib , medicine , thyroid cancer , oncology , adverse effect , cancer , hepatocellular carcinoma
The aim of this meta-analysis was to analyze the relationship of toxicities and clinical benefits of newly approved lenvatinib and sorafenib to thyroid cancer (TC) in patients.